✦ LIBER ✦

A Rare Novel Tyrosine Hydroxylase Gene Deletion in Parkinson Disease

✍ Scribed by James R. Lupski

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 71 KB
Volume: 31
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.21370

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A rare novel deletion of the tyrosine hy

A rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease

✍ Güney Bademci; Todd L. Edwards; Andre L. Torres; William K. Scott; Stephan Züchn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Tyrosine hydroxylase (TH) enzyme is a rate limiting enzyme in dopamine biosynthesis. Missense mutation in both alleles of the __TH__ gene is known to cause dopamine-related phenotypes, including dystonia and infantile Parkinsonism. However, it is not clear if single allele mutation in __TH__ modifie

Deletion in the tyrosine hydroxylase gen

Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype

✍ Aida Ormazabal; Mercedes Serrano; Angels Garcia-Cazorla; Jaume Campistol; Rafael 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 676 KB

Erratum: Deletion in the tyrosine hydrox

Erratum: Deletion in the tyrosine hydroxylase gene in a patient with a mild phenotype

📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

The publisher regrets the error.

Levodopa-responsive infantile parkinsoni

Levodopa-responsive infantile parkinsonism due to a novel mutation in the tyrosine hydroxylase gene and exacerbation by viral infections

✍ Katharina Diepold; Barbara Schütz; Kevin Rostasy; Bernd Wilken; Pia Hougaard; Fl 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

## Abstract Autosomal recessive forms of infantile dystonia due to mutations in the tyrosine hydroxylase (__TH__) gene have been described recently. The main clinical manifestations are Segawa's disease, or infantile hypokinetic rigid Parkinsonism. Here, we report on a patient with hyperrigidity, p

Intravenous glial-derived neurotrophic f

Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter

✍ Chun-Fang Xia; Ruben J. Boado; Yun Zhang; Chun Chu; William M. Pardridge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 455 KB

## Abstract ## Background Rats with experimental Parkinson's disease (PD) are treated with intravenous glial‐derived neurotrophic factor (GDNF) plasmid DNA, non‐viral gene therapy using Trojan horse liposomes (THLs) targeted with a monoclonal antibody (MAb) to the rat transferrin receptor (TfR). E

G209A Mutation in the α-synuclein gene i

G209A Mutation in the α-synuclein gene is rare and not associated with sporadic Parkinson's disease

✍ Dr. Shu-Leong Ho; Michelle H. W. Kung 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Recent interest has focused on the largest pedigree reported to date with histologically proven Lewy body parkinsonism with an autosomal-dominant mode of transmission.' It consisted of descendants of several immigrants to the United States linked to collateral Italian descendants by a common ancesto